Image

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Recruiting
18-24 years
Female
Phase N/A

Powered by AI

Overview

Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention.

The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years.

The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group.

Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained.

Research Questions

Does HPV education delivered through different methods increase HPV knowledge levels among young women?

Does HPV education increase HPV vaccination intention compared with the control group?

Is face-to-face education more effective than video-based education in increasing vaccination intention?

Are the improvements in knowledge and vaccination intention sustained one month after the education?

Description

This study is a randomized controlled intervention designed to evaluate the effects of different educational methods on HPV and HPV vaccination knowledge level and vaccination intention among young women aged 18-24 living in the Afşin district of Kahramanmaraş, Türkiye. Participants will be randomly assigned into three groups: control group, video-based education group, and face-to-face education group.

At the beginning of the study, a pre-test will be administered to determine participants' baseline HPV and HPV vaccine knowledge and vaccination intention. Educational interventions prepared in accordance with national health guidelines will be delivered to the intervention groups, while no training will be provided to the control group. Immediately after the education sessions, a post-test will be applied to assess short-term effects, and a follow-up assessment one month later will evaluate the persistence of the effect.

Data will be collected at three time points using an introductory information form, the HPV Knowledge Scale, and the HPV Vaccination Attitude and Intention Form. The findings will be used to compare the effectiveness of different educational methods on HPV knowledge level and vaccination intention.

Eligibility

Inclusion Criteria:

Participants must meet all of the following criteria to be included in the study:

Aged 18-24 years,

Residing in Afşin district, Kahramanmaraş province,

Willing to voluntarily participate in the study,

Literate and able to understand survey questions in Turkish,

Have not previously received the HPV vaccine,

Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test),

Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study.

Exclusion Criteria:

Participants will be excluded if they meet any of the following conditions:

Under 18 or over 24 years of age,

Have received the HPV vaccine or started the vaccine series,

Have been diagnosed with HPV infection,

Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),

Illiterate or unable to understand the study forms in Turkish,

Withdraw from the study or indicate unwillingness to continue participation,

Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.

Study details
    Human Papillomavirus (HPV) Infection
    HPV Vaccination Acceptance/Intention

NCT07420556

Emel GÜÇLÜ CİHAN

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.